WASEDA University Ventures
VC Fund
Tokyo, Japan
WASEDA University Ventures is a VC fund in Tokyo focused on Medical and Biotechnology. The goal of Waseda University's founding principles is to create businesses and industries that contribute to the evolution and well-being of human society and sustainability by implementing academic knowledge and research results into society through the creation and development of start-ups that use learning and "the practical application of scholarship."
- Total investments:
- 14
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries WASEDA University Ventures invests in
Stages WASEDA University Ventures invests in
Countries WASEDA University Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.2M–$38M
- Series A
- $1.3M–$14M
Investment Focus
Industry
- Medical 4 (29%)
- Biotechnology 4 (29%)
- Information Technology 3 (21%)
- Commercial 2 (14%)
- Health Care 2 (14%)
Stage
- Seed 6 (43%)
- Series A 6 (43%)
- Convertible Note 1 (7%)
- Venture - Series Unknown 1 (7%)
Country
- Japan 10 (71%)
- United States 1 (7%)
- United Kingdom 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hiroaki Ohta
Representative Director, General Partner, Board Member
|
Representative Director, General Partner, Board Member | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases. | $1.4M / Venture - Series Unknown / Sep 07, 2026 | ||
| Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation. | $2M / Seed / Jun 24, 2026 | ||
| Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies. | $1.3M / Series A / Apr 22, 2026 | ||
| CoreTissue BioEngineering is a development of an artificial ligament for reconstruction of the anterior cruciate ligament in Japan. | $3.9M / Series A / Nov 10, 2025 | ||
| Tres Alchemix is an AI-driven biotechnology company focused on accelerating drug discovery, predicting drug efficacy, and developing novel therapeutic compounds using advanced machine learning and data-driven approaches. | $4.4M / Series A / Sep 26, 2025 | ||
| Nanofiber Quantum Technologies is a research and manufacturing company that develops hardware for quantum communications. Its technologies provide quantum computers using nanofibers and advanced engineering, specializing in quantum cryptography, quantum communications, and other technologies related to quantum science for social implementation. | $14M / Series A / Sep 25, 2025 | ||
| VETA strives to minimize friction caused by value differences in society through cutting-edge social science research. | $1.4M / Seed / Jun 24, 2025 | ||
| Power Diamond Systems is a research and development firm that focuses on diamond semiconductor devices. | $4.5M / Seed / Nov 21, 2024 | ||
| BioPhenoMA develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases. | $1.2M / Seed / Nov 07, 2024 | ||
| Quanmatic is an information and technology company that provides algorithms development and solutions to bridge quantum technologies. | $3.7M / Series A / Sep 30, 2024 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does WASEDA University Ventures invest in?
WASEDA University Ventures invests primarily in Medical, Biotechnology and Information Technology startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does WASEDA University Ventures invest in?
WASEDA University Ventures typically joins rounds of $1.2M–$38M at Seed and $1.3M–$14M at Series A. These are whole funding-round sizes, not WASEDA University Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds WASEDA University Ventures took part in.
How do I contact WASEDA University Ventures?
Public channels for WASEDA University Ventures include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at WASEDA University Ventures?
The team at WASEDA University Ventures includes Hiroaki Ohta (Representative Director, General Partner, Board Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
